| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $63K | -14.4% |
| Cost of Revenue | $589K | +62.9% |
| Gross Profit | -$526K | -82.7% |
| R&D Expense | $36K | +0.7% |
| SG&A Expense | $4.8M | +789.5% |
| Operating Income | -$5.4M | -520.8% |
| Pre-tax Income | -$5.4M | -533.0% |
| Income Tax | $0 | — |
| Net Income | -$5.4M | -533.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23K | -40.5% |
| Accounts Receivable | $20K | -3.9% |
| Current Assets | $68K | +9.4% |
| Total Assets | $230K | -62.6% |
| Current Liabilities | $5.0M | +58.9% |
| Total Liabilities | $5.0M | +59.0% |
| Stockholders' Equity | -$4.8M | -88.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | -703.4% |
| Capital Expenditures | $169K | +5329.0% |
| Investing Cash Flow | -$173K | +68.2% |
| Financing Cash Flow | $1.8M | +141.6% |
| Free Cash Flow | -$1.9M | -771.0% |